XML 42 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Liabilities Subject to Compromise (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 26, 2021
Dec. 25, 2020
Schedule of Liabilities Subject to Compromise [Line Items]    
Liabilities Subject to Compromise $ 5,914.2 $ 4,192.6
Lease rejection    
Schedule of Liabilities Subject to Compromise [Line Items]    
Increase (Decrease) Other current and non-current liabilities 34.8  
Contingent Consideration    
Schedule of Liabilities Subject to Compromise [Line Items]    
Increase (Decrease) Other current and non-current liabilities 15.6  
Accounts Payable    
Schedule of Liabilities Subject to Compromise [Line Items]    
Liabilities Subject to Compromise 52.9 61.9
Interest Payable, Current    
Schedule of Liabilities Subject to Compromise [Line Items]    
Liabilities Subject to Compromise 35.2 35.2
Long-term Debt    
Schedule of Liabilities Subject to Compromise [Line Items]    
Liabilities Subject to Compromise [1] 3,446.5 1,660.7
Long-term Debt | Term Loans due Sept 2024 and Feb 2025    
Schedule of Liabilities Subject to Compromise [Line Items]    
Liabilities Subject to Compromise 1,785.8  
Medicaid Lawsuit [Member]    
Schedule of Liabilities Subject to Compromise [Line Items]    
Liabilities Subject to Compromise 638.9 638.9
Opioid-related litigation settlement liability    
Schedule of Liabilities Subject to Compromise [Line Items]    
Liabilities Subject to Compromise 1,600.0 1,600.0
Other current and non-current liabilities    
Schedule of Liabilities Subject to Compromise [Line Items]    
Liabilities Subject to Compromise 108.1 163.5
Liability, Defined Benefit Plan, Noncurrent    
Schedule of Liabilities Subject to Compromise [Line Items]    
Liabilities Subject to Compromise $ 32.6 $ 32.4
[1] In connection with the Company’s Chapter 11 Cases, $3,446.5 million and $1,660.7 million outstanding secured and unsecured debt instruments have been reclassified to LSTC in the Company's unaudited condensed consolidated balance sheets as of March 26, 2021 and December 25, 2020, respectively. Up to the date of reclassification to LSTC, the Company continued to accrue interest expense in relation to these debt instruments reclassified to LSTC. Refer to Note 2 for further information